Navigation Links
Dynatronics Announces Changes to Board and Launches Operational Improvement Process
Date:12/17/2008

SALT LAKE CITY, Dec. 17 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) today announced changes to its board of directors and the execution of an agreement with a former director for consulting services designed to aid in strategic planning and improved corporate profitability. On December 15, 2008, the company entered into an agreement with Vici Capital Partners for consulting services through its principal, Mark Crockett. As a condition to the execution of the agreement, Mr. Crockett resigned from Dynatronics' board of directors, where he had served as an independent director.

"In his short time on the board, Mark Crockett provided tremendous insight and service," said Kelvyn Cullimore Jr., chief executive officer of Dynatronics. "While we regret losing his services as an independent director we are thrilled he is willing to make that sacrifice in order to roll up his sleeves on the inside of the company."

Mr. Crockett has previously led the operational turnaround efforts of a number of companies and will now be helping Dynatronics in an intensive effort to improve all aspects of its business. "After acquiring and integrating several of our key dealers this past year, we are now poised to complete the transformation of our company to more fully take advantage of our strategic strengths as a manufacturer and distributor of medical products for the physical medicine market," added Cullimore.

NASDAQ Marketplace Rules require that a majority of a company's board be comprised of independent directors. To maintain a majority of independent directors following Mr. Crockett's resignation, Dynatronics accepted the resignation of Kelvyn Cullimore, Sr., the company's founder and vice-chairman of the board. Mr. Cullimore's resignation from the board will not affect his duties managing Dynatronics' Synergie products division and Tennessee operations. The company's board of directors now has five members, three of whom are independent under applicable NASDAQ rules and SEC regulations.

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at http://www.dynatronics.com.

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements. Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2008, and its subsequent quarterly reports on Form 10-Q.


'/>"/>
SOURCE Dynatronics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynatronics Announces Strong Fourth Quarter Profit
2. Dynatronics Adds Three Additional Direct Sales Reps
3. Dynatronics to Release First Quarter Results Monday, November 19, 2007; Conference Call Set for 1:30 p.m. ET
4. Dynatronics Acquisitions Increase Sales 91 Percent in First Quarter
5. Dynatronics Announces $250,000 Increase in Stock Buyback Program
6. Dynatronics to Release Second Quarter Results Thursday, February 14, 2008; Conference Call Set for 4:30 p.m. ET
7. Dynatronics Acquisitions Increase Sales 100 Percent in Second Quarter
8. Dynatronics Introduces New Synergie Elite Aesthetic Line
9. Dynatronics Introduces New DynaPro Spinal Health System and X5 Turbo
10. Dynatronics Reduces Annual Expenses by $1.9 Million
11. Dynatronics to Release Third Quarter Results Wednesday, May 14, 2008; Conference Call Set for 2:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... 2017 , ... TransPixel Volume 2 is a set of transitions that create ... effect isolates horizontal and vertical lines of pixels and sorts their pixels by darkness, ... animation and can be changed using a drop-down menu. Create amazing and artistic transitions ...
(Date:7/20/2017)... , ... July 20, 2017 , ... ... firm headquartered in Houston, is pleased to announce their expansion to the Midwest ... housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John Peck ...
(Date:7/20/2017)... ... July 20, 2017 , ... Doctors on Liens, the leading ... Horine Chiropractic , directed by Dr. Russell Horine, DC to their exclusive list ... run with Dr. Russell Horine serving as the clinic director and his son Dr. ...
(Date:7/20/2017)... ... July 20, 2017 , ... The Dermatology Clinic announced today the ... his BS in Biology from LSU, graduating summa cum laude. He attended Emory University ... his residency in St. Louis, Dr. Dunbar moved to New York to complete an ...
(Date:7/20/2017)... ... July 20, 2017 , ... With nearly half of ... insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a new cloud-based solution platform ... products online, under their own brand. The online marketplace bridges the technological gap ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... 2017 The Institute for In Vitro Sciences ... recipient of a VITROCELL® inhalation exposure system thanks to ... The device, which is designed to replace animals in ... cells to airborne test materials in an environment that ... system for testing combustible tobacco products, as well as ...
Breaking Medicine Technology: